Sangamo Therapeutics (SGMO)
(Delayed Data from NSDQ)
$0.78 USD
-0.01 (-1.45%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $0.79 +0.01 (1.15%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth B Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/06/2024
Time: -- |
9/2024 | $-0.07 | 0.00% |
Earnings Summary
For their last quarter, Sangamo Therapeutics (SGMO) reported earnings of -$0.17 per share, missing the Zacks Consensus Estimate of -$0.16 per share. This reflects a negative earnings surprise of 6.25%. Look out for SGMO's next earnings release expected on November 06, 2024. For the next earning release, we expect the company to report earnings of -$0.07 per share, reflecting a year-over-year increase of 79.41%.
Earnings History
Price & Consensus
Zacks News for SGMO
Adaptive Biotechnologies (ADPT) Reports Q2 Loss, Tops Revenue Estimates
SGMO: What are Zacks experts saying now?
Zacks Private Portfolio Services